findmyKOL
Clinical trialNCT00473928CompletedPhase 1Interventional

Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)

SponsorPotentia Pharmaceuticals, Inc.Enrollment27Age-Related Macular Degeneration
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objective of this study is to provide initial safety and tolerability information of intravitreal POT-4 for treatment of patients with AMD

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • United States, Arizona

    Tucson, Arizona, United States

  • United States, California

    Beverly Hills, California, United States

  • United States, Florida

    Gainesville, Florida, United States

  • United States, Florida

    Miami, Florida, United States

  • United States, Minnesota

    Rochester, Minnesota, United States

  • United States, New Hampshire

    Portsmouth, New Hampshire, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

POT-4
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2007
Primary completion
28 Feb 2010
Completion
28 Feb 2010
Last update posted
18 Mar 2010
Registered enrollment
27
Registry id
NCT00473928

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.